Try our beta test site
22 studies found for:    "Myelodysplastic Syndromes" | Austria
Show Display Options
Rank Status Study
1 Completed Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases
Conditions: Myeloproliferative Disorder;   Myelodysplastic Syndromes;   Pulmonary Hypertension
Intervention: Other: echocardiography, right heart catheterisation
2 Recruiting An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Subjects With Acute Myeloid Leukemia (AML)
Conditions: Leukemia, Myeloid, Acute;   Myelodysplastic Syndromes
Interventions: Drug: Azacitidine;   Drug: Durvalumab
3 Recruiting Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project
Conditions: Acute Myeloid Leukemia (AML);   Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)
4 Withdrawn Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Intervention: Biological: lintuzumab
5 Unknown  Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Intervention: Drug: decitabine
6 Active, not recruiting
Has Results
Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Condition: MDS
Interventions: Drug: Darbepoetin alfa;   Drug: Placebo
7 Active, not recruiting
Has Results
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q
Condition: Anemia
Interventions: Drug: Lenalidomide;   Other: Placebo
8 Recruiting Registry on Hypomethylating Agents in Myeloid Neoplasms
Conditions: Chronic Myelomonocytic Leukemia;   Myelodysplastic Syndromes;   Acute Myeloid Leukemia
Intervention: Other: non interventional
9 Completed A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
Condition: Thrombocytopaenia
Interventions: Drug: Eltrombopag;   Drug: Azacitidine;   Drug: Placebo
10 Active, not recruiting A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).
Conditions: Myelodysplastic Syndromes;   Chronic Myelomonocytic Leukemia;   Acute Myeloid Leukemia
Interventions: Drug: Panobinostat (LBH589) and 5-Azacytidine;   Drug: 5-Azacytidine
11 Recruiting Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Conditions: Myelodysplastic Syndrome;   MDS;   Refractory Anemia With Excess Blasts;   RAEB
Interventions: Drug: rigosertib;   Drug: Any approved or standard-of-care therapy;   Drug: best supportive care (BSC)
12 Recruiting Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)
Conditions: Myelodysplastic Syndrome;   Leukemia, Myelomonocytic, Juvenile
Intervention: Drug: Azacitidine
13 Recruiting Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
Conditions: Adult;   Myelodysplastic Syndromes
Interventions: Other: questionnaire administration;   Other: fatigue assessment and management;   Other: observation;   Other: quality-of-life assessment
14 Unknown  Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome
Conditions: Anemia;   Myelodysplastic Syndromes
Interventions: Biological: epoetin alfa;   Drug: amifostine trihydrate
15 Recruiting A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes (MDS)
Intervention: Other: No interventions
16 Unknown  Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Procedure: allogeneic hematopoietic stem cell transplantation
17 Active, not recruiting Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies
Conditions: Acute Lymphoblastic Leukaemias (ALL);   Acute Myeloid Leukaemias (AML);   Myelodysplastic Syndromes (MDS);   Juvenile Myelomonocytic Leukaemias (JMML)
Intervention: Drug: Treosulfan
18 Completed Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment
Conditions: Dyskeratosis Congenita;   Fanconi Anemia;   Myelodysplastic Syndromes;   Pearson Marrow-pancreas Syndrome;   Shwachman-diamond Syndrome
Interventions: Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: immunologic technique;   Procedure: biopsy
19 Recruiting Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation
Condition: Chronic Iron Overload
Intervention: Drug: Deferasirox
20 Completed A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
Condition: Transfusion-dependent Iron Overload
Intervention: Drug: Deferasirox

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.